Mebias Discovery Receives Grant from NIDA to Advance MEB‑1170 as an Analgesic Drug Candidate for the Prevention and Treatment of Opioid Use Disorder 
Grant to Fund IND Enabling and Phase 1 Clinical Trials

Preclinical Data Demonstrates MEB‑1170 Lacks Dangerous Side Effects Including Respiratory Depression and Opioid Abuse Potential

See more here


Annovis Bio Resumes Treatment of Patients in Ongoing Phase 2a Study in Alzheimer’s Disease After COVID-Related Delay

See more here


Relmada Therapeutics Expands R&D Team, Appoints Paolo Manfredi, M.D., as Acting Chief Scientific Officer, Marco Pappagallo, M.D., as Acting Chief Medical Officer and Updates R&D Milestones 

See more here


Envara Health Launches Encala® to Enhance Fat Absorption and Provide Healthy Calories for Patients with Cystic Fibrosis
New, innovative therapy brings breakthrough science and clinical evidence to nutrition

Helps patients with malabsorption meet their weight and nutritional needs   

See more here


Halo Labs Announces New Products and Leadership Changes
Dr. Joseph Keegan, Executive Chairman, to Assume Interim Leadership 

See more here


Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering

See more here


Annovis Bio Demonstrates Improved Axonal Transport in Nerve Cells and Brain of Down Syndrome Mice, an Animal Model of Alzheimer’s Disease
Manuscript Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association

Study adds further validation that Annovis’ lead compound is the only drug to improve axonal transport, the information highway of the nerve cell   

See more here


IVIEW Collaboration With Dr. Amin Javer at St. Paul’s Hospital and Sinus Centre, Canada to Study Povidone Iodine Formulations Including IVIEW-1503, a Long-Lasting Povidone Iodine Nasal Spray for the Treatment of COVID-19

See more here